I was recently pointed to something I hadn’t seen before – a version of Dr. Charlie Nemeroff’s CV that had a listing of his tenure on the advisory boards of various pharmaceutical companies including time served on each. It adds another dimension to the compilation of his published articles and the GSK PsychNET Speaker trips […]
I think what I’m talking about here is the biggest of deals. The topic is about a debate in psychiatry that happened well over a quarter of a century ago, one that really has never been resolved – it just faded away before its time. It has to do with the nature of depressive illness. […]
Recently, I spent a long time reviewing the events leading up to the DSM-III Revision focusing on the Feighner Criteria, the Research Diagnostic Criteria, and the process that lead to that revision [the future of an illusion I…, the dreams of our fathers I…]. Those series were more for me than a reader. The goings […]
Is there any possible benign reason that the APA DSM-5 Task Force failed to release the results of their Field Trials prior to the end of the final period for comments? I can’t think of one off-hand. I expect that they were as disappointed with the results as the rest of us have been [what […]
A year ago, looking into the personalized medicine craze, I ran across an Australian Group, Brain Resource, that seemed dead-set on turning the idea into an entrepreneurial block-buster with everything from Brain Training to MRIs. Here’s founder Evian Gordon, Guru/Scientist/Pitchman in a short video [notice the techno-voice, also there when he speaks at the end […]
It’s really something I didn’t anticipate – that they would actually fail to post the Field Trial results during the period when the DSM-5 was accepting comments. It’s not like they didn’t have the results. They had them at the APA meeting 6 weeks ago – probably long before that. Are we supposed to pretend […]
Ghosts In The Pharma Attic: Jon & Jeff Explain Pharmalot By Ed Silverman June 12th, 2012 … Some might say it is a minor point but in academic medicine there is currently an institutionalized loophole in place, that essentially says that anyone deserving of the term “author” should be listed on the byline, unless they […]
Professors [Allen] Frances and [Patrick] McGorry are keynote speakers at the Asia South Pacific Mental Health Conference hosted by the Richmond Fellowship in Perth [Australia], which ends today… Mental health needs rethink thewest.com.au by Martin Whitely June 13, 2012 Mental health policy in Australia, for so long ignored, is finally getting attention. The Gillard and […]
Experimental Medicine NIMH Director’s Blog By Thomas Insel June 12, 2012 In previous posts I have described the crisis of medication development for mental disorders. Medications developed over the past five decades have been prescribed widely but have not been sufficient for reducing the morbidity and mortality of mental disorders. Yet there is diminishing activity […]